Lin Shao-Lee (CIK 1725092) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-07). Recent activity: Buy CUE (327,537 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | Cue Biopharma, Inc. (CUE) | CHIEF EXECUTIVE OFFICER | Buy | 327,537 | $0 |
Source: SEC Form 4 filings · as of 2026-05-07